Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;34(2):e14853.
doi: 10.1111/dth.14853. Epub 2021 Feb 18.

Successful treatment of a bullous vasculitis with intravenous immunoglobulins in a COVID-19 patient

Elisa Zavattaro  1   2 , Edoardo Cammarata  1   3 , Vanessa Tarantino  1   3 , Daniele Soddu  1   2 , Laura C Gironi  1 , Paola Savoia  1   3
Affiliations

Successful treatment of a bullous vasculitis with intravenous immunoglobulins in a COVID-19 patient

Elisa Zavattaro et al. Dermatol Ther. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Purpuric macules and papules involving lower extremities, with bullae and initial aspects of central ulceration and necrosis; (B) Extension of the lesions beyond the lower limbs, with diffuse necrotic aspects; (C) Clinical feature 1 month after the disease onset
See this image and copyright information in PMC

References

    1. Negrini S, Guadagno A, Greco M, Parodi A, Burlando M. An unusual case of bullous hemorrhagic vasculitis in a COVID‐19 patient. J Eur Acad Dermatol Venereol. 2020;34(11):e675‐e676. 10.1111/jdv.16760. - DOI - PMC - PubMed
    1. Wollina U, Karadağ AS, Rowland‐Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID‐19 patients: a review. Dermatol Ther. 2020;33:e13549. 10.1111/dth.13549. - DOI - PMC - PubMed
    1. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid19. N Engl J Med. 2020;382(17):e38. - PMC - PubMed
    1. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375cases. Br J Dermatol. 2020;183(1):71‐77. - PMC - PubMed
    1. Genovese G, Moltrasio C, Berti E, Marzano AV. Skin manifestations associated with COVID‐19: current knowledge and future perspectives. Dermatology. 2020;237:1‐12. 10.1159/000512932. - DOI - PMC - PubMed

Substances